Re: Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial

被引：0
|
作者：
Resnick, Matthew J.
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 202卷 / 05期
关键词：
D O I：
10.1097/01.JU.0000579852.12966.fc
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：859 / 860
页数：2
相关论文
共 50 条
  • [1] Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI The STOPDAPT-2 Randomized Clinical Trial
    Watanabe, Hirotoshi
    Domei, Takenori
    Morimoto, Takeshi
    Natsuaki, Masahiro
    Shiomi, Hiroki
    Toyota, Toshiaki
    Ohya, Masanobu
    Suwa, Satoru
    Takagi, Kensuke
    Nanasato, Mamoru
    Hata, Yoshiki
    Yagi, Masahiro
    Suematsu, Nobuhiro
    Yokomatsu, Takafumi
    Takamisawa, Itaru
    Doi, Masayuki
    Noda, Toshiyuki
    Okayama, Hideki
    Seino, Yoshitane
    Tada, Tomohisa
    Sakamoto, Hiroki
    Hibi, Kiyoshi
    Abe, Mitsuru
    Kawai, Kazuya
    Nakao, Koichi
    Ando, Kenji
    Tanabe, Kengo
    Ikari, Yuji
    Hanaoka, Keiichi Igarashi
    Morino, Yoshihiro
    Kozuma, Ken
    Kadota, Kazushige
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Kimura, Takeshi
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (24): : 2414 - 2427
  • [2] Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2
    Watanabe, Hirotoshi
    Morimoto, Takeshi
    Ogita, Manabu
    Suwa, Satoru
    Natsuaki, Masahiro
    Suematsu, Nobuhiro
    Koeda, Yorihiko
    Morino, Yoshihiro
    Nikaido, Akira
    Hata, Yoshiki
    Doi, Masayuki
    Hibi, Kiyoshi
    Kimura, Kazuo
    Yoda, Shunsuke
    Kaneko, Takeo
    Nishida, Koji
    Kawai, Kazuya
    Yamaguchi, Koji
    Wakatsuki, Tetsuzo
    Tonoike, Norimasa
    Yamamoto, Masashi
    Shimizu, Shogo
    Shimohama, Takao
    Ako, Junya
    Kimura, Takeshi
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2021, 36 (04) : 403 - 415
  • [3] Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome The STOPDAPT-2 ACS Randomized Clinical Trial
    Watanabe, Hirotoshi
    Morimoto, Takeshi
    Natsuaki, Masahiro
    Yamamoto, Ko
    Obayashi, Yuki
    Ogita, Manabu
    Suwa, Satoru
    Isawa, Tsuyoshi
    Domei, Takenori
    Yamaji, Kyohei
    Tatsushima, Shojiro
    Watanabe, Hiroki
    Ohya, Masanobu
    Tokuyama, Hideo
    Tada, Tomohisa
    Sakamoto, Hiroki
    Mori, Hiroyoshi
    Suzuki, Hiroshi
    Nishikura, Tenjin
    Wakabayashi, Kohei
    Hibi, Kiyoshi
    Abe, Mitsuru
    Kawai, Kazuya
    Nakao, Koichi
    Ando, Kenji
    Tanabe, Kengo
    Ikari, Yuji
    Morino, Yoshihiro
    Kadota, Kazushige
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Kimura, Takeshi
    JAMA CARDIOLOGY, 2022, 7 (04) : 407 - 417
  • [4] Correction to: Influence of CYP2C19 genotypes for the effect of 1‑month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12‑month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT‑2
    Hirotoshi Watanabe
    Takeshi Morimoto
    Manabu Ogita
    Satoru Suwa
    Masahiro Natsuaki
    Nobuhiro Suematsu
    Yorihiko Koeda
    Yoshihiro Morino
    Akira Nikaido
    Yoshiki Hata
    Masayuki Doi
    Kiyoshi Hibi
    Kazuo Kimura
    Shunsuke Yoda
    Takeo Kaneko
    Koji Nishida
    Kazuya Kawai
    Koji Yamaguchi
    Tetsuzo Wakatsuki
    Norimasa Tonoike
    Masashi Yamamoto
    Shogo Shimizu
    Takao Shimohama
    Junya Ako
    Takeshi Kimura
    Cardiovascular Intervention and Therapeutics, 2021, 36 : 416 - 417
  • [5] Clopidogrel Monotherapy After 1-Month Dual Anti platelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort
    Obayashi, Yuki
    Watanabe, Hirotoshi
    Morimoto, Takeshi
    Yamamoto, Ko
    Natsuaki, Masahiro
    Domei, Takenori
    Yamaji, Kyohei
    Suwa, Satoru
    Isawa, Tsuyoshi
    Watanabe, Hiroki
    Yoshida, Ruka
    Sakamoto, Hiroki
    Akao, Masaharu
    Hata, Yoshiki
    Morishima, Itsuro
    Tokuyama, Hideo
    Yagi, Masahiro
    Suzuki, Hiroshi
    Wakabayashi, Kohei
    Suematsu, Nobuhiro
    Inada, Tsukasa
    Tamura, Toshihiro
    Okayama, Hideki
    Abe, Mitsuru
    Kawai, Kazuya
    Nakao, Koichi
    Ando, Kenji
    Tanabe, Kengo
    Ikari, Yuji
    Morino, Yoshihiro
    Kadota, Kazushige
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Kimura, Takeshi
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (08) : E012004
  • [6] Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention
    Yamamoto, Ko
    Watanabe, Hirotoshi
    Morimoto, Takeshi
    Obayashi, Yuki
    Natsuaki, Masahiro
    Yamaji, Kyohei
    Domei, Takenori
    Ogita, Manabu
    Ohya, Masanobu
    Tatsushima, Shojiro
    Suzuki, Hirohiko
    Tada, Tomohisa
    Ishii, Mitsuru
    Nikaido, Akira
    Watanabe, Naoki
    Fujii, Shinya
    Mori, Hiroyoshi
    Nishikura, Tenjin
    Suematsu, Nobuhiro
    Hayashi, Fujio
    Komiyama, Kota
    Shigematsu, Tatsuya
    Isawa, Tsuyoshi
    Suwa, Satoru
    Ando, Kenji
    Kimura, Takeshi
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (01) : 19 - 31
  • [7] Comparison of 1-month vs. 12-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: the ULTIMATE-DAPT trial
    Vranckx, Pascal
    Valgimigli, Marco
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2024, 13 (04) : 368 - 369
  • [8] Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents
    Park, Taek Kyu
    Song, Young Bin
    Ahn, Joonghyun
    Carriere, K. C.
    Hahn, Joo-Yong
    Yang, Jeong Hoon
    Choi, Seung-Hyuk
    Choi, Jin-Ho
    Lee, Sang Hoon
    Gwon, Hyeon-Cheol
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (01)
  • [9] Short Dual Antiplatelet Therapy in High Bleeding Risk Patients 1 Month or 3 Months?
    Capodanno, Davide
    Greco, Antonio
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (20) : 2511 - 2513
  • [10] P2Y12 INHIBITOR MONOTHERAPY AFTER A SHORT DUAL ANTIPLATELET THERAPY VS. 12-MONTH DUAL ANTIPLATELET THERAPY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS
    Ling, Hua
    Egolum, Ugochukwu
    Parker, Shanea
    Ho, Ai-Chen
    Dimmel, Jordan
    Hawkins, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 73 - 73
12345